Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel

Combinatorial therapeutic strategies to eradicate tumors can be superior to a single therapeutic modality. Docetaxel (DT) has been approved for the treatment of local or metastasized breast cancer alone or in combination with other chemotherapeutic agents. Thymoquinone (TQ) originated from the seeds...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Fadwa Odeh, Randa Naffa, Hanan Azzam, Ismail S. Mahmoud, Walhan Alshaer, Abeer Al Bawab, Said Ismail
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2019-11-01
Serie:Heliyon
Ämnen:
Cancer research
Pharmaceutical science
Breast cancer
Docetaxel
Thymoquinone
Liposomes
Länkar:http://www.sciencedirect.com/science/article/pii/S2405844019365788
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk